Datamonitor
Slow recovery expected for epilepsy market
May 27, 2010Sales and Marketing Datamonitor, Keppra, UCB, epilepsy
The global market for epilepsy treatments is expected to make a slow recovery after a wave of patent expiries from …
Drug repositioning a ‘key strategy’ for pharma
July 17, 2009Research and Development Datamonitor, strategy
With increased investment in R&D largely failing to fill drug development pipelines, the pharma industry is looking to get more …
Little benefit to pharma from G20 initiatives
April 22, 2009Research and Development, Sales and Marketing Datamonitor, strategy
Any positive effect on the pharmaceutical industry derived from the G20 summit and European Union summit will be indirect and …
Latest content
Global coalition calls for stronger government action on COPD
September 18, 2026
Global health researchers call for more equitable partnerships
September 17, 2026
Liverpool launches £20m lab for infectious disease drug discovery
September 16, 2026
Circle Health Group expands into UK laboratory operations
September 15, 2026
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
September 14, 2026
